A dominant mutation in RPE65 identified by whole-exome sequencing causes retinitis pigmentosa with choroidal involvement

Sara J. Bowne, Marian M. Humphries, Lori S. Sullivan, Paul F. Kenna, Lawrence C S Tam, Anna S. Kiang, Matthew Campbell, George M. Weinstock, Daniel C. Koboldt, Li Ding, Robert S. Fulton, Erica J. Sodergren, Denis Allman, Sophia Millington-Ward, Arpad Palfi, Alex McKee, Susan H Blanton, Susan Slifer, Ioanna Konidari, G. Jane FarrarStephen P. Daiger, Peter Humphries

Research output: Contribution to journalArticle

80 Citations (Scopus)

Abstract

Linkage testing using Affymetrix 6.0 SNP Arrays mapped the disease locus in TCD-G, an Irish family with autosomal dominant retinitis pigmentosa (adRP), to an 8.8 Mb region on 1p31. Of 50 known genes in the region, 11 candidates, including RPE65 and PDE4B, were sequenced using di-deoxy capillary electrophoresis. Simultaneously, a subset of family members was analyzed using Agilent SureSelect All Exome capture, followed by sequencing on an Illumina GAIIx platform. Candidate gene and exome sequencing resulted in the identification of an Asp477Gly mutation in exon 13 of the RPE65 gene tracking with the disease in TCD-G. All coding exons of genes not sequenced to sufficient depth by next generation sequencing were sequenced by di-deoxy sequencing. No other potential disease-causing variants were found to segregate with disease in TCD-G. The Asp477Gly mutation was not present in Irish controls, but was found in a second Irish family provisionally diagnosed with choroideremia, bringing the combined maximum two-point LOD score to 5.3. Mutations in RPE65 are a known cause of recessive Leber congenital amaurosis (LCA) and recessive RP, but no dominant mutations have been reported. Protein modeling suggests that the Asp477Gly mutation may destabilize protein folding, and mutant RPE65 protein migrates marginally faster on SDS-PAGE, compared with wild type. Gene therapy for LCA patients with RPE65 mutations has shown great promise, raising the possibility of related therapies for dominant-acting mutations in this gene.

Original languageEnglish
Pages (from-to)1074-1081
Number of pages8
JournalEuropean Journal of Human Genetics
Volume19
Issue number10
DOIs
StatePublished - Oct 1 2011

Fingerprint

Exome
Retinitis Pigmentosa
Mutation
Leber Congenital Amaurosis
Genes
Exons
Choroideremia
Protein Folding
Capillary Electrophoresis
Mutant Proteins
Genetic Therapy
Single Nucleotide Polymorphism
Polyacrylamide Gel Electrophoresis

Keywords

  • choroideremia
  • exome capture
  • next-generation sequencing
  • retinitis pigmentosa
  • RPE65

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics

Cite this

Bowne, S. J., Humphries, M. M., Sullivan, L. S., Kenna, P. F., Tam, L. C. S., Kiang, A. S., ... Humphries, P. (2011). A dominant mutation in RPE65 identified by whole-exome sequencing causes retinitis pigmentosa with choroidal involvement. European Journal of Human Genetics, 19(10), 1074-1081. https://doi.org/10.1038/ejhg.2011.86

A dominant mutation in RPE65 identified by whole-exome sequencing causes retinitis pigmentosa with choroidal involvement. / Bowne, Sara J.; Humphries, Marian M.; Sullivan, Lori S.; Kenna, Paul F.; Tam, Lawrence C S; Kiang, Anna S.; Campbell, Matthew; Weinstock, George M.; Koboldt, Daniel C.; Ding, Li; Fulton, Robert S.; Sodergren, Erica J.; Allman, Denis; Millington-Ward, Sophia; Palfi, Arpad; McKee, Alex; Blanton, Susan H; Slifer, Susan; Konidari, Ioanna; Farrar, G. Jane; Daiger, Stephen P.; Humphries, Peter.

In: European Journal of Human Genetics, Vol. 19, No. 10, 01.10.2011, p. 1074-1081.

Research output: Contribution to journalArticle

Bowne, SJ, Humphries, MM, Sullivan, LS, Kenna, PF, Tam, LCS, Kiang, AS, Campbell, M, Weinstock, GM, Koboldt, DC, Ding, L, Fulton, RS, Sodergren, EJ, Allman, D, Millington-Ward, S, Palfi, A, McKee, A, Blanton, SH, Slifer, S, Konidari, I, Farrar, GJ, Daiger, SP & Humphries, P 2011, 'A dominant mutation in RPE65 identified by whole-exome sequencing causes retinitis pigmentosa with choroidal involvement', European Journal of Human Genetics, vol. 19, no. 10, pp. 1074-1081. https://doi.org/10.1038/ejhg.2011.86
Bowne, Sara J. ; Humphries, Marian M. ; Sullivan, Lori S. ; Kenna, Paul F. ; Tam, Lawrence C S ; Kiang, Anna S. ; Campbell, Matthew ; Weinstock, George M. ; Koboldt, Daniel C. ; Ding, Li ; Fulton, Robert S. ; Sodergren, Erica J. ; Allman, Denis ; Millington-Ward, Sophia ; Palfi, Arpad ; McKee, Alex ; Blanton, Susan H ; Slifer, Susan ; Konidari, Ioanna ; Farrar, G. Jane ; Daiger, Stephen P. ; Humphries, Peter. / A dominant mutation in RPE65 identified by whole-exome sequencing causes retinitis pigmentosa with choroidal involvement. In: European Journal of Human Genetics. 2011 ; Vol. 19, No. 10. pp. 1074-1081.
@article{e230665e973844278b2595d1332f52b2,
title = "A dominant mutation in RPE65 identified by whole-exome sequencing causes retinitis pigmentosa with choroidal involvement",
abstract = "Linkage testing using Affymetrix 6.0 SNP Arrays mapped the disease locus in TCD-G, an Irish family with autosomal dominant retinitis pigmentosa (adRP), to an 8.8 Mb region on 1p31. Of 50 known genes in the region, 11 candidates, including RPE65 and PDE4B, were sequenced using di-deoxy capillary electrophoresis. Simultaneously, a subset of family members was analyzed using Agilent SureSelect All Exome capture, followed by sequencing on an Illumina GAIIx platform. Candidate gene and exome sequencing resulted in the identification of an Asp477Gly mutation in exon 13 of the RPE65 gene tracking with the disease in TCD-G. All coding exons of genes not sequenced to sufficient depth by next generation sequencing were sequenced by di-deoxy sequencing. No other potential disease-causing variants were found to segregate with disease in TCD-G. The Asp477Gly mutation was not present in Irish controls, but was found in a second Irish family provisionally diagnosed with choroideremia, bringing the combined maximum two-point LOD score to 5.3. Mutations in RPE65 are a known cause of recessive Leber congenital amaurosis (LCA) and recessive RP, but no dominant mutations have been reported. Protein modeling suggests that the Asp477Gly mutation may destabilize protein folding, and mutant RPE65 protein migrates marginally faster on SDS-PAGE, compared with wild type. Gene therapy for LCA patients with RPE65 mutations has shown great promise, raising the possibility of related therapies for dominant-acting mutations in this gene.",
keywords = "choroideremia, exome capture, next-generation sequencing, retinitis pigmentosa, RPE65",
author = "Bowne, {Sara J.} and Humphries, {Marian M.} and Sullivan, {Lori S.} and Kenna, {Paul F.} and Tam, {Lawrence C S} and Kiang, {Anna S.} and Matthew Campbell and Weinstock, {George M.} and Koboldt, {Daniel C.} and Li Ding and Fulton, {Robert S.} and Sodergren, {Erica J.} and Denis Allman and Sophia Millington-Ward and Arpad Palfi and Alex McKee and Blanton, {Susan H} and Susan Slifer and Ioanna Konidari and Farrar, {G. Jane} and Daiger, {Stephen P.} and Peter Humphries",
year = "2011",
month = "10",
day = "1",
doi = "10.1038/ejhg.2011.86",
language = "English",
volume = "19",
pages = "1074--1081",
journal = "European Journal of Human Genetics",
issn = "1018-4813",
publisher = "Nature Publishing Group",
number = "10",

}

TY - JOUR

T1 - A dominant mutation in RPE65 identified by whole-exome sequencing causes retinitis pigmentosa with choroidal involvement

AU - Bowne, Sara J.

AU - Humphries, Marian M.

AU - Sullivan, Lori S.

AU - Kenna, Paul F.

AU - Tam, Lawrence C S

AU - Kiang, Anna S.

AU - Campbell, Matthew

AU - Weinstock, George M.

AU - Koboldt, Daniel C.

AU - Ding, Li

AU - Fulton, Robert S.

AU - Sodergren, Erica J.

AU - Allman, Denis

AU - Millington-Ward, Sophia

AU - Palfi, Arpad

AU - McKee, Alex

AU - Blanton, Susan H

AU - Slifer, Susan

AU - Konidari, Ioanna

AU - Farrar, G. Jane

AU - Daiger, Stephen P.

AU - Humphries, Peter

PY - 2011/10/1

Y1 - 2011/10/1

N2 - Linkage testing using Affymetrix 6.0 SNP Arrays mapped the disease locus in TCD-G, an Irish family with autosomal dominant retinitis pigmentosa (adRP), to an 8.8 Mb region on 1p31. Of 50 known genes in the region, 11 candidates, including RPE65 and PDE4B, were sequenced using di-deoxy capillary electrophoresis. Simultaneously, a subset of family members was analyzed using Agilent SureSelect All Exome capture, followed by sequencing on an Illumina GAIIx platform. Candidate gene and exome sequencing resulted in the identification of an Asp477Gly mutation in exon 13 of the RPE65 gene tracking with the disease in TCD-G. All coding exons of genes not sequenced to sufficient depth by next generation sequencing were sequenced by di-deoxy sequencing. No other potential disease-causing variants were found to segregate with disease in TCD-G. The Asp477Gly mutation was not present in Irish controls, but was found in a second Irish family provisionally diagnosed with choroideremia, bringing the combined maximum two-point LOD score to 5.3. Mutations in RPE65 are a known cause of recessive Leber congenital amaurosis (LCA) and recessive RP, but no dominant mutations have been reported. Protein modeling suggests that the Asp477Gly mutation may destabilize protein folding, and mutant RPE65 protein migrates marginally faster on SDS-PAGE, compared with wild type. Gene therapy for LCA patients with RPE65 mutations has shown great promise, raising the possibility of related therapies for dominant-acting mutations in this gene.

AB - Linkage testing using Affymetrix 6.0 SNP Arrays mapped the disease locus in TCD-G, an Irish family with autosomal dominant retinitis pigmentosa (adRP), to an 8.8 Mb region on 1p31. Of 50 known genes in the region, 11 candidates, including RPE65 and PDE4B, were sequenced using di-deoxy capillary electrophoresis. Simultaneously, a subset of family members was analyzed using Agilent SureSelect All Exome capture, followed by sequencing on an Illumina GAIIx platform. Candidate gene and exome sequencing resulted in the identification of an Asp477Gly mutation in exon 13 of the RPE65 gene tracking with the disease in TCD-G. All coding exons of genes not sequenced to sufficient depth by next generation sequencing were sequenced by di-deoxy sequencing. No other potential disease-causing variants were found to segregate with disease in TCD-G. The Asp477Gly mutation was not present in Irish controls, but was found in a second Irish family provisionally diagnosed with choroideremia, bringing the combined maximum two-point LOD score to 5.3. Mutations in RPE65 are a known cause of recessive Leber congenital amaurosis (LCA) and recessive RP, but no dominant mutations have been reported. Protein modeling suggests that the Asp477Gly mutation may destabilize protein folding, and mutant RPE65 protein migrates marginally faster on SDS-PAGE, compared with wild type. Gene therapy for LCA patients with RPE65 mutations has shown great promise, raising the possibility of related therapies for dominant-acting mutations in this gene.

KW - choroideremia

KW - exome capture

KW - next-generation sequencing

KW - retinitis pigmentosa

KW - RPE65

UR - http://www.scopus.com/inward/record.url?scp=80053050730&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053050730&partnerID=8YFLogxK

U2 - 10.1038/ejhg.2011.86

DO - 10.1038/ejhg.2011.86

M3 - Article

C2 - 21654732

AN - SCOPUS:80053050730

VL - 19

SP - 1074

EP - 1081

JO - European Journal of Human Genetics

JF - European Journal of Human Genetics

SN - 1018-4813

IS - 10

ER -